GUJARAT THEMIS BIOSYN
Back to Income Statement
|
GUJARAT THEMIS BIOSYN Last 5 Year Revenue History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹151 Cr | ₹170 Cr | ₹148 Cr | ₹115 Cr | ₹91 Cr |
What is the latest Revenue of GUJARAT THEMIS BIOSYN ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹151 Cr |
| Mar2024 | ₹170 Cr |
| Mar2023 | ₹148 Cr |
| Mar2022 | ₹115 Cr |
| Mar2021 | ₹91 Cr |
How is Revenue of GUJARAT THEMIS BIOSYN Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹151 Cr | -11.20 | |
| Mar2024 | ₹170 Cr | 14.45 | |
| Mar2023 | ₹148 Cr | 29.19 | |
| Mar2022 | ₹115 Cr | 26.82 | |
| Mar2021 | ₹91 Cr | - | |
Compare Revenue of peers of GUJARAT THEMIS BIOSYN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GUJARAT THEMIS BIOSYN | ₹4,379.1 Cr | -7.3% | 7.7% | 29% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹429,349.0 Cr | -3% | -1.9% | 7.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹174,543.0 Cr | -3.3% | -0.7% | -1.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,884.0 Cr | -3.8% | 2.8% | 36.4% | Stock Analytics | |
| CIPLA | ₹111,077.0 Cr | -3% | 3% | -6.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,388.0 Cr | -4.3% | -2% | 2.5% | Stock Analytics | |
GUJARAT THEMIS BIOSYN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GUJARAT THEMIS BIOSYN | -7.3% |
7.7% |
29% |
| SENSEX | -2.2% |
-3.3% |
-8.8% |
You may also like the below Video Courses